March 14, 2022 – Stroke is an acute disease of the brain and the most common cause of permanent disability in adults in ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
March 13, 2022 – Philips has announced new research evaluating mobile cardiac outpatient telemetry (MCOT) as a first ...
March 13, 2022 – People with a congenital heart defect who were hospitalized with COVID-19 infection were at higher risk ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
March 9, 2022 – Point-of-care screening for atrial fibrillation (A-fib) using a new generation of handheld electrocardio ...
February 28, 2022 – iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the ...
February 16, 2022 – A new way of treating arrhythmias, including atrial fibrillation (AF) — the most common heart ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
February 14, 2022 — Philips, a global leader in health technology, is supporting the American Heart Association’s multi ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
January 14, 2022 — Medtronic has entered into a definitive agreement to acquire Affera Inc., a Boston area-based ...
January 5, 2022 — Stereotaxis announced a recent publication in Frontiers in Cardiovascular Medicine titled “Atrial ...
Improved short-term monitoring methods for patients with stroke risk can increase early detection of atrial fibrillation ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
November 22, 2021 — BioSig Technologies Inc., a medical technology company commercializing an innovative biomedical ...
November 17, 2021 — People with atrial fibrillation (AFib) who underwent individualized testing to discover triggers for ...
November 16, 2021 — Acutus Medical Inc. (Acutus), an arrhythmia management company focused on improving the way cardiac ...